4//SEC Filing
Pepose Jay 4
Accession 0001140361-22-014327
CIK 0001228627other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 1:56 PM ET
Size
5.4 KB
Accession
0001140361-22-014327
Insider Transaction Report
Form 4
Pepose Jay
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-08+50,000→ 50,000 totalExercise: $2.90Exp: 2032-04-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option will vest with respect to 12,500 shares on March 31, 2023, and then with respect to 1,041 shares on the last day of each month from April 2023 through February 2026 and with respect to 1,065 shares at the end of March 2026, subject to the Reporting Person's continuing service through each applicable vesting date.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001866191
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 1:56 PM ET
- Size
- 5.4 KB